Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of TAK-906 in Japanese Healthy Males
NCT03237156Phase 1Completed
- Sponsor
- Takeda
- Start
- Aug 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of trazpiroben in gastroparesis (6 arms), sponsored by Takeda. Primary endpoints: Treatment-Emergent Adverse Events, Markedly Abnormal Values of Vital Signs and 2 more. Started Aug 2017; status: completed.
02
Drugs
trazpiroben
03
Conditions
gastroparesis
Beyond the preview
Go deeper on NCT03237156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03237156.